Department of Dietetics, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences (SGGW-WULS), 159C Nowoursynowska Street, 02-776 Warsaw, Poland.
Department of Food Market and Consumer Research, Institute of Human Nutrition Sciences, Warsaw University of Life Sciences (SGGW-WULS), 159C Nowoursynowska Street, 02-776 Warsaw, Poland.
Nutrients. 2022 Jul 23;14(15):3023. doi: 10.3390/nu14153023.
Pregnant women are among the population groups most vulnerable to the development of anemia, as the overall iron requirement during pregnancy is significantly higher than in non-pregnant women. The aim of the systematic review was to assess the effectiveness of dietary interventions in the prevention and treatment of iron-deficiency anemia in pregnant women based on randomized-controlled trials. The systematic review was based on the PRISMA guidelines and is registered in the PROSPERO database (CRD42021261235). The search was conducted within PubMed and Web of Science databases for the period until June 2021. The included randomized controlled trials presented effectiveness of dietary interventions in prevention and treatment of iron-deficiency anemia in pregnant women. From the total number of 7825 screened records, the final number of seven studies were included in the systematic review. The procedure of screening, inclusion, reporting, and assessment of the risk of bias while using the revised Cochrane risk of bias tool for randomized trials was conducted by two independent researchers. The studies included in the systematic review were conducted in populations of anemic pregnant women, or mixed populations of anemic and non-anemic pregnant women. The interventions described within the studies were associated with including fortified products, regular products, or dietary counselling. They were based on providing an increased amount of iron, providing an increased amount of multiple nutrients, or general counselling only, while effectiveness was compared with effectiveness of the placebo, supplementation, or control group. The study duration was diversified from a few weeks to half a year or longer. The major biochemical measure assessed within the included studies was hemoglobin. All applied dietary interventions, based on providing increased amount of iron, providing increased amount of multiple nutrients, or general counselling only, were effective. The majority of included studies were assessed as ones of a medium risk of bias. For some studies a high risk of bias was indicated, which resulted from a risk of bias arising from the randomization process, due to deviations from the intended interventions, and in selection of the reported result. Considering this fact, more randomized controlled trials should be planned and conducted in a rigorous manner to confirm the formulated observations of effectiveness of the studied interventions based on providing an increased amount of iron, providing an increased amount of multiple nutrients, or general counselling only.
孕妇是易患贫血人群之一,因为怀孕期间的总铁需求明显高于非孕妇。本系统评价的目的是基于随机对照试验评估饮食干预对预防和治疗孕妇缺铁性贫血的效果。系统评价基于 PRISMA 指南,并在 PROSPERO 数据库(CRD42021261235)中注册。该检索在 PubMed 和 Web of Science 数据库中进行,检索时间截至 2021 年 6 月。纳入的随机对照试验报告了饮食干预对预防和治疗孕妇缺铁性贫血的效果。在总共 7825 条筛选记录中,最终有 7 项研究纳入系统评价。两名独立研究人员对筛选、纳入、报告程序以及使用修订后的 Cochrane 随机试验偏倚风险工具评估偏倚风险进行了评估。纳入系统评价的研究是在贫血孕妇人群或贫血和非贫血孕妇混合人群中进行的。研究中描述的干预措施与强化产品、常规产品或饮食咨询有关。它们基于提供更多的铁、提供更多的多种营养素或仅进行一般性咨询,而有效性则与安慰剂、补充剂或对照组的有效性进行比较。研究持续时间从数周到半年或更长时间不等。纳入研究中主要评估的生化指标是血红蛋白。所有应用的饮食干预措施,基于提供更多的铁、提供更多的多种营养素或仅进行一般性咨询,都是有效的。纳入的大多数研究被评估为具有中等偏倚风险。一些研究被认为具有高偏倚风险,这是由于随机化过程、偏离预期干预措施以及对报告结果的选择而导致的偏倚风险。考虑到这一点,应该计划和进行更多的随机对照试验,以严格的方式确认基于提供更多的铁、提供更多的多种营养素或仅进行一般性咨询的所研究干预措施的有效性观察结果。